nodes	percent_of_prediction	percent_of_DWPC	metapath
Procainamide—BCHE—Triamcinolone—psoriasis	0.135	0.492	CbGbCtD
Procainamide—CYP2D6—Hydroxyurea—psoriasis	0.0615	0.224	CbGbCtD
Procainamide—CYP2D6—Cholecalciferol—psoriasis	0.0373	0.136	CbGbCtD
Procainamide—CYP2D6—Cyclosporine—psoriasis	0.0245	0.0892	CbGbCtD
Procainamide—CYP2D6—Dexamethasone—psoriasis	0.0161	0.0588	CbGbCtD
Procainamide—Sunitinib—TYK2—psoriasis	0.0075	1	CrCbGaD
Procainamide—DNMT1—Budesonide—Clobetasol propionate—psoriasis	0.00221	0.0844	CbGdCrCtD
Procainamide—DNMT1—Budesonide—Beclomethasone—psoriasis	0.00177	0.0676	CbGdCrCtD
Procainamide—DNMT1—Budesonide—Fluocinonide—psoriasis	0.00177	0.0676	CbGdCrCtD
Procainamide—DNMT1—Budesonide—Fluocinolone Acetonide—psoriasis	0.00172	0.0657	CbGdCrCtD
Procainamide—DNMT1—Dexamethasone—Clobetasol propionate—psoriasis	0.00135	0.0516	CbGdCrCtD
Procainamide—DNMT1—Betamethasone—Clobetasol propionate—psoriasis	0.00135	0.0516	CbGdCrCtD
Procainamide—Confusional state—Mycophenolic acid—psoriasis	0.00128	0.00184	CcSEcCtD
Procainamide—Hallucination—Hydrocortisone—psoriasis	0.00127	0.00184	CcSEcCtD
Procainamide—Dizziness—Acitretin—psoriasis	0.00127	0.00184	CcSEcCtD
Procainamide—Dizziness—Fluocinolone Acetonide—psoriasis	0.00127	0.00183	CcSEcCtD
Procainamide—Chills—Mycophenolate mofetil—psoriasis	0.00126	0.00182	CcSEcCtD
Procainamide—Feeling abnormal—Hydroxyurea—psoriasis	0.00125	0.0018	CcSEcCtD
Procainamide—Shock—Mycophenolic acid—psoriasis	0.00125	0.0018	CcSEcCtD
Procainamide—Thrombocytopenia—Mycophenolic acid—psoriasis	0.00124	0.00179	CcSEcCtD
Procainamide—Dysgeusia—Cyclosporine—psoriasis	0.00123	0.00178	CcSEcCtD
Procainamide—Bradycardia—Triamcinolone—psoriasis	0.00123	0.00177	CcSEcCtD
Procainamide—Vomiting—Acitretin—psoriasis	0.00122	0.00177	CcSEcCtD
Procainamide—Vomiting—Fluocinolone Acetonide—psoriasis	0.00122	0.00176	CcSEcCtD
Procainamide—Anorexia—Mycophenolic acid—psoriasis	0.00121	0.00174	CcSEcCtD
Procainamide—Dysgeusia—Mycophenolate mofetil—psoriasis	0.0012	0.00173	CcSEcCtD
Procainamide—Body temperature increased—Hydroxyurea—psoriasis	0.00119	0.00173	CcSEcCtD
Procainamide—Hypotension—Mycophenolic acid—psoriasis	0.00118	0.00171	CcSEcCtD
Procainamide—Lethargy—Methotrexate—psoriasis	0.00118	0.0017	CcSEcCtD
Procainamide—Ill-defined disorder—Cyclosporine—psoriasis	0.00116	0.00168	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Mycophenolic acid—psoriasis	0.00115	0.00167	CcSEcCtD
Procainamide—Angioedema—Cyclosporine—psoriasis	0.00115	0.00166	CcSEcCtD
Procainamide—Nausea—Acitretin—psoriasis	0.00114	0.00165	CcSEcCtD
Procainamide—Nausea—Fluocinolone Acetonide—psoriasis	0.00114	0.00165	CcSEcCtD
Procainamide—Ill-defined disorder—Mycophenolate mofetil—psoriasis	0.00114	0.00164	CcSEcCtD
Procainamide—Malaise—Cyclosporine—psoriasis	0.00113	0.00164	CcSEcCtD
Procainamide—Angioedema—Mycophenolate mofetil—psoriasis	0.00112	0.00162	CcSEcCtD
Procainamide—Bradycardia—Betamethasone—psoriasis	0.00111	0.00161	CcSEcCtD
Procainamide—Bradycardia—Dexamethasone—psoriasis	0.00111	0.00161	CcSEcCtD
Procainamide—Hypersensitivity—Hydroxyurea—psoriasis	0.00111	0.00161	CcSEcCtD
Procainamide—Neutropenia—Prednisone—psoriasis	0.00111	0.00161	CcSEcCtD
Procainamide—Malaise—Mycophenolate mofetil—psoriasis	0.0011	0.0016	CcSEcCtD
Procainamide—Decreased appetite—Mycophenolic acid—psoriasis	0.0011	0.00159	CcSEcCtD
Procainamide—Hallucination—Betamethasone—psoriasis	0.00109	0.00157	CcSEcCtD
Procainamide—Hallucination—Dexamethasone—psoriasis	0.00109	0.00157	CcSEcCtD
Procainamide—Convulsion—Cyclosporine—psoriasis	0.00109	0.00157	CcSEcCtD
Procainamide—Asthenia—Hydroxyurea—psoriasis	0.00108	0.00157	CcSEcCtD
Procainamide—DNMT1—Betamethasone—Fluocinonide—psoriasis	0.00108	0.0414	CbGdCrCtD
Procainamide—DNMT1—Dexamethasone—Beclomethasone—psoriasis	0.00108	0.0414	CbGdCrCtD
Procainamide—DNMT1—Dexamethasone—Fluocinonide—psoriasis	0.00108	0.0414	CbGdCrCtD
Procainamide—DNMT1—Betamethasone—Beclomethasone—psoriasis	0.00108	0.0414	CbGdCrCtD
Procainamide—Arthralgia—Cyclosporine—psoriasis	0.00107	0.00154	CcSEcCtD
Procainamide—Myalgia—Cyclosporine—psoriasis	0.00107	0.00154	CcSEcCtD
Procainamide—Convulsion—Mycophenolate mofetil—psoriasis	0.00106	0.00153	CcSEcCtD
Procainamide—Ill-defined disorder—Prednisolone—psoriasis	0.00106	0.00153	CcSEcCtD
Procainamide—Depression—Prednisone—psoriasis	0.00106	0.00153	CcSEcCtD
Procainamide—Discomfort—Cyclosporine—psoriasis	0.00106	0.00153	CcSEcCtD
Procainamide—DNMT1—Dexamethasone—Fluocinolone Acetonide—psoriasis	0.00105	0.0402	CbGdCrCtD
Procainamide—DNMT1—Betamethasone—Fluocinolone Acetonide—psoriasis	0.00105	0.0402	CbGdCrCtD
Procainamide—Angioedema—Prednisolone—psoriasis	0.00104	0.00151	CcSEcCtD
Procainamide—Feeling abnormal—Mycophenolic acid—psoriasis	0.00104	0.00151	CcSEcCtD
Procainamide—Arthralgia—Mycophenolate mofetil—psoriasis	0.00104	0.00151	CcSEcCtD
Procainamide—Myalgia—Mycophenolate mofetil—psoriasis	0.00104	0.00151	CcSEcCtD
Procainamide—Gastrointestinal pain—Mycophenolic acid—psoriasis	0.00104	0.0015	CcSEcCtD
Procainamide—Ill-defined disorder—Hydrocortisone—psoriasis	0.00103	0.0015	CcSEcCtD
Procainamide—Diarrhoea—Hydroxyurea—psoriasis	0.00103	0.00149	CcSEcCtD
Procainamide—Confusional state—Cyclosporine—psoriasis	0.00103	0.00149	CcSEcCtD
Procainamide—Malaise—Prednisolone—psoriasis	0.00103	0.00149	CcSEcCtD
Procainamide—Discomfort—Mycophenolate mofetil—psoriasis	0.00103	0.00149	CcSEcCtD
Procainamide—Dysgeusia—Triamcinolone—psoriasis	0.00103	0.00149	CcSEcCtD
Procainamide—Angioedema—Hydrocortisone—psoriasis	0.00102	0.00147	CcSEcCtD
Procainamide—Confusional state—Mycophenolate mofetil—psoriasis	0.00101	0.00146	CcSEcCtD
Procainamide—Malaise—Hydrocortisone—psoriasis	0.00101	0.00145	CcSEcCtD
Procainamide—Thrombocytopenia—Cyclosporine—psoriasis	0.001	0.00145	CcSEcCtD
Procainamide—Abdominal pain—Mycophenolic acid—psoriasis	0.001	0.00145	CcSEcCtD
Procainamide—Body temperature increased—Mycophenolic acid—psoriasis	0.001	0.00145	CcSEcCtD
Procainamide—Dizziness—Hydroxyurea—psoriasis	0.000999	0.00144	CcSEcCtD
Procainamide—Convulsion—Prednisolone—psoriasis	0.000989	0.00143	CcSEcCtD
Procainamide—Eosinophilia—Methotrexate—psoriasis	0.000985	0.00142	CcSEcCtD
Procainamide—Shock—Mycophenolate mofetil—psoriasis	0.000983	0.00142	CcSEcCtD
Procainamide—Thrombocytopenia—Mycophenolate mofetil—psoriasis	0.000978	0.00141	CcSEcCtD
Procainamide—Anorexia—Cyclosporine—psoriasis	0.000976	0.00141	CcSEcCtD
Procainamide—Ill-defined disorder—Triamcinolone—psoriasis	0.000974	0.00141	CcSEcCtD
Procainamide—Bradycardia—Prednisone—psoriasis	0.00097	0.0014	CcSEcCtD
Procainamide—Convulsion—Hydrocortisone—psoriasis	0.000966	0.0014	CcSEcCtD
Procainamide—Vomiting—Hydroxyurea—psoriasis	0.000961	0.00139	CcSEcCtD
Procainamide—Discomfort—Prednisolone—psoriasis	0.00096	0.00139	CcSEcCtD
Procainamide—Angioedema—Triamcinolone—psoriasis	0.000959	0.00139	CcSEcCtD
Procainamide—Abdominal discomfort—Methotrexate—psoriasis	0.000954	0.00138	CcSEcCtD
Procainamide—Anorexia—Mycophenolate mofetil—psoriasis	0.000952	0.00138	CcSEcCtD
Procainamide—Myalgia—Hydrocortisone—psoriasis	0.000949	0.00137	CcSEcCtD
Procainamide—Hallucination—Prednisone—psoriasis	0.000948	0.00137	CcSEcCtD
Procainamide—Malaise—Triamcinolone—psoriasis	0.000947	0.00137	CcSEcCtD
Procainamide—Discomfort—Hydrocortisone—psoriasis	0.000938	0.00136	CcSEcCtD
Procainamide—Hypotension—Mycophenolate mofetil—psoriasis	0.000934	0.00135	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Cyclosporine—psoriasis	0.000933	0.00135	CcSEcCtD
Procainamide—Neutropenia—Methotrexate—psoriasis	0.000931	0.00135	CcSEcCtD
Procainamide—Shock—Prednisolone—psoriasis	0.000917	0.00133	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Mycophenolate mofetil—psoriasis	0.00091	0.00132	CcSEcCtD
Procainamide—Convulsion—Triamcinolone—psoriasis	0.00091	0.00132	CcSEcCtD
Procainamide—Asthenia—Mycophenolic acid—psoriasis	0.000908	0.00131	CcSEcCtD
Procainamide—Nausea—Hydroxyurea—psoriasis	0.000898	0.0013	CcSEcCtD
Procainamide—Pruritus—Mycophenolic acid—psoriasis	0.000896	0.00129	CcSEcCtD
Procainamide—Shock—Hydrocortisone—psoriasis	0.000895	0.00129	CcSEcCtD
Procainamide—Myalgia—Triamcinolone—psoriasis	0.000894	0.00129	CcSEcCtD
Procainamide—Decreased appetite—Cyclosporine—psoriasis	0.00089	0.00129	CcSEcCtD
Procainamide—Depression—Methotrexate—psoriasis	0.000885	0.00128	CcSEcCtD
Procainamide—Flushing—Prednisone—psoriasis	0.000885	0.00128	CcSEcCtD
Procainamide—Ill-defined disorder—Betamethasone—psoriasis	0.000884	0.00128	CcSEcCtD
Procainamide—Ill-defined disorder—Dexamethasone—psoriasis	0.000884	0.00128	CcSEcCtD
Procainamide—Discomfort—Triamcinolone—psoriasis	0.000883	0.00128	CcSEcCtD
Procainamide—Renal failure—Methotrexate—psoriasis	0.000872	0.00126	CcSEcCtD
Procainamide—Angioedema—Betamethasone—psoriasis	0.000871	0.00126	CcSEcCtD
Procainamide—Angioedema—Dexamethasone—psoriasis	0.000871	0.00126	CcSEcCtD
Procainamide—Decreased appetite—Mycophenolate mofetil—psoriasis	0.000868	0.00126	CcSEcCtD
Procainamide—Anorexia—Hydrocortisone—psoriasis	0.000868	0.00125	CcSEcCtD
Procainamide—DNMT1—Budesonide—Hydrocortisone—psoriasis	0.000867	0.0332	CbGdCrCtD
Procainamide—Diarrhoea—Mycophenolic acid—psoriasis	0.000866	0.00125	CcSEcCtD
Procainamide—Malaise—Dexamethasone—psoriasis	0.000859	0.00124	CcSEcCtD
Procainamide—Malaise—Betamethasone—psoriasis	0.000859	0.00124	CcSEcCtD
Procainamide—Hypotension—Hydrocortisone—psoriasis	0.00085	0.00123	CcSEcCtD
Procainamide—Feeling abnormal—Cyclosporine—psoriasis	0.000844	0.00122	CcSEcCtD
Procainamide—Shock—Triamcinolone—psoriasis	0.000843	0.00122	CcSEcCtD
Procainamide—Gastrointestinal pain—Cyclosporine—psoriasis	0.000837	0.00121	CcSEcCtD
Procainamide—Dizziness—Mycophenolic acid—psoriasis	0.000837	0.00121	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Hydrocortisone—psoriasis	0.000829	0.0012	CcSEcCtD
Procainamide—Agranulocytosis—Methotrexate—psoriasis	0.000828	0.0012	CcSEcCtD
Procainamide—Convulsion—Dexamethasone—psoriasis	0.000826	0.00119	CcSEcCtD
Procainamide—Convulsion—Betamethasone—psoriasis	0.000826	0.00119	CcSEcCtD
Procainamide—Feeling abnormal—Mycophenolate mofetil—psoriasis	0.000823	0.00119	CcSEcCtD
Procainamide—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	0.000817	0.00118	CcSEcCtD
Procainamide—Urticaria—Cyclosporine—psoriasis	0.000814	0.00118	CcSEcCtD
Procainamide—Myalgia—Betamethasone—psoriasis	0.000811	0.00117	CcSEcCtD
Procainamide—Myalgia—Dexamethasone—psoriasis	0.000811	0.00117	CcSEcCtD
Procainamide—Abdominal pain—Cyclosporine—psoriasis	0.00081	0.00117	CcSEcCtD
Procainamide—Body temperature increased—Cyclosporine—psoriasis	0.00081	0.00117	CcSEcCtD
Procainamide—DNMT1—Budesonide—Betamethasone—psoriasis	0.000805	0.0308	CbGdCrCtD
Procainamide—DNMT1—Budesonide—Dexamethasone—psoriasis	0.000805	0.0308	CbGdCrCtD
Procainamide—Vomiting—Mycophenolic acid—psoriasis	0.000805	0.00116	CcSEcCtD
Procainamide—Discomfort—Betamethasone—psoriasis	0.000801	0.00116	CcSEcCtD
Procainamide—Discomfort—Dexamethasone—psoriasis	0.000801	0.00116	CcSEcCtD
Procainamide—Urticaria—Mycophenolate mofetil—psoriasis	0.000794	0.00115	CcSEcCtD
Procainamide—Decreased appetite—Hydrocortisone—psoriasis	0.000791	0.00114	CcSEcCtD
Procainamide—Abdominal pain—Mycophenolate mofetil—psoriasis	0.00079	0.00114	CcSEcCtD
Procainamide—Body temperature increased—Mycophenolate mofetil—psoriasis	0.00079	0.00114	CcSEcCtD
Procainamide—DNMT1—Budesonide—Triamcinolone—psoriasis	0.000787	0.0301	CbGdCrCtD
Procainamide—Musculoskeletal discomfort—Triamcinolone—psoriasis	0.000781	0.00113	CcSEcCtD
Procainamide—Ill-defined disorder—Prednisone—psoriasis	0.00077	0.00111	CcSEcCtD
Procainamide—Feeling abnormal—Prednisolone—psoriasis	0.000768	0.00111	CcSEcCtD
Procainamide—Shock—Dexamethasone—psoriasis	0.000765	0.00111	CcSEcCtD
Procainamide—Shock—Betamethasone—psoriasis	0.000765	0.00111	CcSEcCtD
Procainamide—Thrombocytopenia—Dexamethasone—psoriasis	0.000761	0.0011	CcSEcCtD
Procainamide—Thrombocytopenia—Betamethasone—psoriasis	0.000761	0.0011	CcSEcCtD
Procainamide—Angioedema—Prednisone—psoriasis	0.000758	0.0011	CcSEcCtD
Procainamide—Hypersensitivity—Cyclosporine—psoriasis	0.000755	0.00109	CcSEcCtD
Procainamide—Nausea—Mycophenolic acid—psoriasis	0.000752	0.00109	CcSEcCtD
Procainamide—Feeling abnormal—Hydrocortisone—psoriasis	0.00075	0.00108	CcSEcCtD
Procainamide—Malaise—Prednisone—psoriasis	0.000748	0.00108	CcSEcCtD
Procainamide—DNMT1—Budesonide—Prednisone—psoriasis	0.000746	0.0286	CbGdCrCtD
Procainamide—Gastrointestinal pain—Hydrocortisone—psoriasis	0.000744	0.00108	CcSEcCtD
Procainamide—Anorexia—Betamethasone—psoriasis	0.000741	0.00107	CcSEcCtD
Procainamide—Anorexia—Dexamethasone—psoriasis	0.000741	0.00107	CcSEcCtD
Procainamide—Urticaria—Prednisolone—psoriasis	0.00074	0.00107	CcSEcCtD
Procainamide—Cardiac disorder—Methotrexate—psoriasis	0.000739	0.00107	CcSEcCtD
Procainamide—Hypersensitivity—Mycophenolate mofetil—psoriasis	0.000736	0.00106	CcSEcCtD
Procainamide—Asthenia—Cyclosporine—psoriasis	0.000735	0.00106	CcSEcCtD
Procainamide—DNMT1—Budesonide—Prednisolone—psoriasis	0.000729	0.0279	CbGdCrCtD
Procainamide—Hypotension—Betamethasone—psoriasis	0.000727	0.00105	CcSEcCtD
Procainamide—Hypotension—Dexamethasone—psoriasis	0.000727	0.00105	CcSEcCtD
Procainamide—Pruritus—Cyclosporine—psoriasis	0.000725	0.00105	CcSEcCtD
Procainamide—Urticaria—Hydrocortisone—psoriasis	0.000723	0.00105	CcSEcCtD
Procainamide—Abdominal pain—Hydrocortisone—psoriasis	0.000719	0.00104	CcSEcCtD
Procainamide—Body temperature increased—Hydrocortisone—psoriasis	0.000719	0.00104	CcSEcCtD
Procainamide—Convulsion—Prednisone—psoriasis	0.000719	0.00104	CcSEcCtD
Procainamide—Asthenia—Mycophenolate mofetil—psoriasis	0.000717	0.00104	CcSEcCtD
Procainamide—Chills—Methotrexate—psoriasis	0.000715	0.00103	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Betamethasone—psoriasis	0.000708	0.00102	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Dexamethasone—psoriasis	0.000708	0.00102	CcSEcCtD
Procainamide—Pruritus—Mycophenolate mofetil—psoriasis	0.000707	0.00102	CcSEcCtD
Procainamide—Myalgia—Prednisone—psoriasis	0.000706	0.00102	CcSEcCtD
Procainamide—Arthralgia—Prednisone—psoriasis	0.000706	0.00102	CcSEcCtD
Procainamide—Feeling abnormal—Triamcinolone—psoriasis	0.000706	0.00102	CcSEcCtD
Procainamide—Diarrhoea—Cyclosporine—psoriasis	0.000701	0.00101	CcSEcCtD
Procainamide—Discomfort—Prednisone—psoriasis	0.000698	0.00101	CcSEcCtD
Procainamide—Hypersensitivity—Prednisolone—psoriasis	0.000687	0.000992	CcSEcCtD
Procainamide—Diarrhoea—Mycophenolate mofetil—psoriasis	0.000684	0.000988	CcSEcCtD
Procainamide—Urticaria—Triamcinolone—psoriasis	0.000681	0.000984	CcSEcCtD
Procainamide—Dysgeusia—Methotrexate—psoriasis	0.000679	0.000982	CcSEcCtD
Procainamide—Body temperature increased—Triamcinolone—psoriasis	0.000677	0.000979	CcSEcCtD
Procainamide—Dizziness—Cyclosporine—psoriasis	0.000677	0.000979	CcSEcCtD
Procainamide—Decreased appetite—Betamethasone—psoriasis	0.000676	0.000977	CcSEcCtD
Procainamide—Decreased appetite—Dexamethasone—psoriasis	0.000676	0.000977	CcSEcCtD
Procainamide—Hypersensitivity—Hydrocortisone—psoriasis	0.000671	0.000969	CcSEcCtD
Procainamide—Shock—Prednisone—psoriasis	0.000666	0.000963	CcSEcCtD
Procainamide—Dizziness—Mycophenolate mofetil—psoriasis	0.000661	0.000955	CcSEcCtD
Procainamide—Asthenia—Hydrocortisone—psoriasis	0.000653	0.000944	CcSEcCtD
Procainamide—Vomiting—Cyclosporine—psoriasis	0.000651	0.000941	CcSEcCtD
Procainamide—Anorexia—Prednisone—psoriasis	0.000646	0.000933	CcSEcCtD
Procainamide—Pruritus—Hydrocortisone—psoriasis	0.000644	0.000931	CcSEcCtD
Procainamide—Ill-defined disorder—Methotrexate—psoriasis	0.000643	0.00093	CcSEcCtD
Procainamide—Feeling abnormal—Dexamethasone—psoriasis	0.000641	0.000926	CcSEcCtD
Procainamide—Feeling abnormal—Betamethasone—psoriasis	0.000641	0.000926	CcSEcCtD
Procainamide—Gastrointestinal pain—Dexamethasone—psoriasis	0.000636	0.000919	CcSEcCtD
Procainamide—Gastrointestinal pain—Betamethasone—psoriasis	0.000636	0.000919	CcSEcCtD
Procainamide—Vomiting—Mycophenolate mofetil—psoriasis	0.000635	0.000918	CcSEcCtD
Procainamide—Hypersensitivity—Triamcinolone—psoriasis	0.000631	0.000913	CcSEcCtD
Procainamide—Malaise—Methotrexate—psoriasis	0.000625	0.000904	CcSEcCtD
Procainamide—Diarrhoea—Hydrocortisone—psoriasis	0.000623	0.0009	CcSEcCtD
Procainamide—Urticaria—Dexamethasone—psoriasis	0.000618	0.000893	CcSEcCtD
Procainamide—Urticaria—Betamethasone—psoriasis	0.000618	0.000893	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Prednisone—psoriasis	0.000617	0.000892	CcSEcCtD
Procainamide—Dizziness—Prednisolone—psoriasis	0.000616	0.000891	CcSEcCtD
Procainamide—Asthenia—Triamcinolone—psoriasis	0.000615	0.000889	CcSEcCtD
Procainamide—Body temperature increased—Dexamethasone—psoriasis	0.000615	0.000888	CcSEcCtD
Procainamide—Body temperature increased—Betamethasone—psoriasis	0.000615	0.000888	CcSEcCtD
Procainamide—Abdominal pain—Betamethasone—psoriasis	0.000615	0.000888	CcSEcCtD
Procainamide—Abdominal pain—Dexamethasone—psoriasis	0.000615	0.000888	CcSEcCtD
Procainamide—Nausea—Cyclosporine—psoriasis	0.000608	0.000879	CcSEcCtD
Procainamide—Pruritus—Triamcinolone—psoriasis	0.000606	0.000876	CcSEcCtD
Procainamide—Dizziness—Hydrocortisone—psoriasis	0.000602	0.00087	CcSEcCtD
Procainamide—Convulsion—Methotrexate—psoriasis	0.000601	0.000868	CcSEcCtD
Procainamide—Nausea—Mycophenolate mofetil—psoriasis	0.000593	0.000858	CcSEcCtD
Procainamide—Arthralgia—Methotrexate—psoriasis	0.00059	0.000853	CcSEcCtD
Procainamide—Myalgia—Methotrexate—psoriasis	0.00059	0.000853	CcSEcCtD
Procainamide—Decreased appetite—Prednisone—psoriasis	0.000589	0.000851	CcSEcCtD
Procainamide—Discomfort—Methotrexate—psoriasis	0.000583	0.000843	CcSEcCtD
Procainamide—Vomiting—Hydrocortisone—psoriasis	0.000579	0.000836	CcSEcCtD
Procainamide—Confusional state—Methotrexate—psoriasis	0.000571	0.000825	CcSEcCtD
Procainamide—Dizziness—Triamcinolone—psoriasis	0.000567	0.000819	CcSEcCtD
Procainamide—Feeling abnormal—Prednisone—psoriasis	0.000558	0.000807	CcSEcCtD
Procainamide—Asthenia—Dexamethasone—psoriasis	0.000558	0.000806	CcSEcCtD
Procainamide—Asthenia—Betamethasone—psoriasis	0.000558	0.000806	CcSEcCtD
Procainamide—Thrombocytopenia—Methotrexate—psoriasis	0.000554	0.000801	CcSEcCtD
Procainamide—Gastrointestinal pain—Prednisone—psoriasis	0.000554	0.0008	CcSEcCtD
Procainamide—Nausea—Prednisolone—psoriasis	0.000554	0.0008	CcSEcCtD
Procainamide—Pruritus—Dexamethasone—psoriasis	0.00055	0.000795	CcSEcCtD
Procainamide—Pruritus—Betamethasone—psoriasis	0.00055	0.000795	CcSEcCtD
Procainamide—Vomiting—Triamcinolone—psoriasis	0.000545	0.000788	CcSEcCtD
Procainamide—Nausea—Hydrocortisone—psoriasis	0.000541	0.000781	CcSEcCtD
Procainamide—Anorexia—Methotrexate—psoriasis	0.000539	0.00078	CcSEcCtD
Procainamide—Urticaria—Prednisone—psoriasis	0.000538	0.000778	CcSEcCtD
Procainamide—Abdominal pain—Prednisone—psoriasis	0.000535	0.000774	CcSEcCtD
Procainamide—Body temperature increased—Prednisone—psoriasis	0.000535	0.000774	CcSEcCtD
Procainamide—Diarrhoea—Betamethasone—psoriasis	0.000532	0.000769	CcSEcCtD
Procainamide—Diarrhoea—Dexamethasone—psoriasis	0.000532	0.000769	CcSEcCtD
Procainamide—DNMT1—Dexamethasone—Hydrocortisone—psoriasis	0.00053	0.0203	CbGdCrCtD
Procainamide—DNMT1—Betamethasone—Hydrocortisone—psoriasis	0.00053	0.0203	CbGdCrCtD
Procainamide—Hypotension—Methotrexate—psoriasis	0.000529	0.000764	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Methotrexate—psoriasis	0.000516	0.000745	CcSEcCtD
Procainamide—Dizziness—Dexamethasone—psoriasis	0.000514	0.000743	CcSEcCtD
Procainamide—Dizziness—Betamethasone—psoriasis	0.000514	0.000743	CcSEcCtD
Procainamide—Nausea—Triamcinolone—psoriasis	0.000509	0.000736	CcSEcCtD
Procainamide—Hypersensitivity—Prednisone—psoriasis	0.000499	0.000721	CcSEcCtD
Procainamide—Vomiting—Dexamethasone—psoriasis	0.000494	0.000715	CcSEcCtD
Procainamide—Vomiting—Betamethasone—psoriasis	0.000494	0.000715	CcSEcCtD
Procainamide—DNMT1—Betamethasone—Dexamethasone—psoriasis	0.000492	0.0188	CbGdCrCtD
Procainamide—DNMT1—Dexamethasone—Betamethasone—psoriasis	0.000492	0.0188	CbGdCrCtD
Procainamide—Decreased appetite—Methotrexate—psoriasis	0.000492	0.000711	CcSEcCtD
Procainamide—Asthenia—Prednisone—psoriasis	0.000486	0.000702	CcSEcCtD
Procainamide—DNMT1—Dexamethasone—Triamcinolone—psoriasis	0.000481	0.0184	CbGdCrCtD
Procainamide—DNMT1—Betamethasone—Triamcinolone—psoriasis	0.000481	0.0184	CbGdCrCtD
Procainamide—Pruritus—Prednisone—psoriasis	0.000479	0.000692	CcSEcCtD
Procainamide—Feeling abnormal—Methotrexate—psoriasis	0.000466	0.000674	CcSEcCtD
Procainamide—Diarrhoea—Prednisone—psoriasis	0.000463	0.00067	CcSEcCtD
Procainamide—Gastrointestinal pain—Methotrexate—psoriasis	0.000463	0.000669	CcSEcCtD
Procainamide—Nausea—Dexamethasone—psoriasis	0.000462	0.000668	CcSEcCtD
Procainamide—Nausea—Betamethasone—psoriasis	0.000462	0.000668	CcSEcCtD
Procainamide—DNMT1—Dexamethasone—Prednisone—psoriasis	0.000457	0.0175	CbGdCrCtD
Procainamide—DNMT1—Betamethasone—Prednisone—psoriasis	0.000457	0.0175	CbGdCrCtD
Procainamide—Urticaria—Methotrexate—psoriasis	0.00045	0.00065	CcSEcCtD
Procainamide—Dizziness—Prednisone—psoriasis	0.000448	0.000647	CcSEcCtD
Procainamide—Body temperature increased—Methotrexate—psoriasis	0.000447	0.000647	CcSEcCtD
Procainamide—Abdominal pain—Methotrexate—psoriasis	0.000447	0.000647	CcSEcCtD
Procainamide—DNMT1—Betamethasone—Prednisolone—psoriasis	0.000446	0.0171	CbGdCrCtD
Procainamide—DNMT1—Dexamethasone—Prednisolone—psoriasis	0.000446	0.0171	CbGdCrCtD
Procainamide—Vomiting—Prednisone—psoriasis	0.000431	0.000622	CcSEcCtD
Procainamide—Hypersensitivity—Methotrexate—psoriasis	0.000417	0.000603	CcSEcCtD
Procainamide—Asthenia—Methotrexate—psoriasis	0.000406	0.000587	CcSEcCtD
Procainamide—Nausea—Prednisone—psoriasis	0.000402	0.000581	CcSEcCtD
Procainamide—Pruritus—Methotrexate—psoriasis	0.0004	0.000579	CcSEcCtD
Procainamide—Diarrhoea—Methotrexate—psoriasis	0.000387	0.00056	CcSEcCtD
Procainamide—Dizziness—Methotrexate—psoriasis	0.000374	0.000541	CcSEcCtD
Procainamide—Vomiting—Methotrexate—psoriasis	0.00036	0.00052	CcSEcCtD
Procainamide—Nausea—Methotrexate—psoriasis	0.000336	0.000486	CcSEcCtD
